Abstract
Physicians are often approached by young women with a BRCA mutation and a recent history of breast cancer who wish to have a baby. They wish to know if pregnancy impacts upon their future risks of cancer recurrence and survival. To date, there is little information on the survival experience of women who carry a mutation in one of the BRCA genes and who become pregnant. From an international multi-center cohort study of 12,084 women with a BRCA1 or BRCA2 mutation, we identified 128 case subjects who were diagnosed with breast cancer while pregnant or who became pregnant after a diagnosis of breast cancer. These women were age-matched to 269 mutation carriers with breast cancer who did not become pregnant (controls). Subjects were followed from the date of breast cancer diagnosis until the date of last follow-up or death from breast cancer. The Kaplan–Meier method was used to estimate 15-year survival rates. The hazard ratio for survival associated with pregnancy was calculated using a left-truncated Cox proportional hazard model, adjusting for other prognostic factors. Among women who were diagnosed with breast cancer when pregnant or who became pregnant thereafter, the 15-year survival rate was 91.5 %, compared to a survival of 88.6 % for women who did not become pregnant (adjusted hazard ratio = 0.76; 95 % CI 0.31–1.91; p = 0.56). Pregnancy concurrent with or after a diagnosis of breast cancer does not appear to adversely affect survival among BRCA1/2 mutation carriers.
Similar content being viewed by others
References
Hayat MJ, Howlader N, Reichman ME, Edwards BK (2007) Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) program. Oncologist 12:20–37
Petrek JA (1994) Breast cancer and pregnancy. J Natl Cancer Inst Monogr 16:113–121
Nugent P, O’Connell TX (1985) Breast cancer and pregnancy. Arch Surg 120:1221–1224
Bonnier P, Romain S, Dilhuydy JM, Bonichon F, Julien JP, Charpin C, Lejeune C, Martin PM, Piana L (1997) Influence of pregnancy on the outcome of breast cancer: a case–control study. Societe Francaise de Senologie et de Pathologie Mammaire Study Group. Int J Cancer 72:720–727
Rodriguez AO, Chew H, Cress R, Xing G, McElvy S, Danielsen B, Smith L (2008) Evidence of poorer survival in pregnancy-associated breast cancer. Obstet Gynecol 112:71–78
Ali SA, Gupta S, Sehgal R, Vogel V (2012) Survival outcomes in pregnancy associated breast cancer: a retrospective case control study. Breast J 18:139–144
Bladström A, Anderson H, Olsson H (2003) Worse survival in breast cancer among women with recent childbirth: results from a Swedish population-based register study. Clin Breast Cancer 4:280–285
Guinee VF, Olsson H, Möller T, Hess KR, Taylor SH, Fahey T, Gladikov JV, van den Blink JW, Bonichon F, Dische S et al (1994) Effect of pregnancy on prognosis for young women with breast cancer. Lancet 343:1587–1589
Azim HA Jr, Botteri E, Renne G, Dell’orto P, Rotmensz N, Gentilini O, Sangalli C, Pruneri G, Di Nubila B, Locatelli M, Sotiriou C, Piccart M, Goldhirsch A, Viale G, Peccatori FA (2012) The biological features and prognosis of breast cancer diagnosed during pregnancy: a case–control study. Acta Oncol 51:653–661
Genin AS, Lesieur B, Gligorov J, Antoine M, Selleret L, Rouzier R (2012) Pregnancy-associated breast cancers: do they differ from other breast cancers in young women? Breast 4:550–555
Ishida T, Yokoe T, Kasumi F, Sakamoto G, Makita M, Tominaga T, Simozuma K, Enomoto K, Fujiwara K, Nanasawa T et al (1992) Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case–control study in Japan. Jpn J Cancer Res 83:1143–1149
Cardonick E, Dougherty R, Grana G, Gilmandyar D, Ghaffar S, Usmani A (2010) Breast cancer during pregnancy: maternal and fetal outcomes. Cancer J 16:76–82
Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Burke B, Sutcliffe SB, Koren G (1992) Maternal and fetal outcome after breast cancer in pregnancy. Am J Obstet Gynecol 166:781–787
Dodds L, Fell DB, Joseph KS, Dewar R, Scott H, Platt R, Aronson KJ (2008) Relationship of time since childbirth and other pregnancy factors to premenopausal breast cancer prognosis. Obstet Gynecol 111:1167–1173
Albrektsen G, Heuch I, Hansen S, Kvale G (2005) Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects. Br J Cancer 17:167–175
Sankila R, Heinavaara S, Hakulinen T (1994) Survival of breast cancer patients after subsequent term pregnancy: “healthy mother effect”. Am J Obstet Gynecol 170:818–823
Keilding N (2005) Delayed entry. In: Armitage P, Colton T (eds) Encyclopedia of biostatistics. Wiley, Hoboken, NJ
Beadle BM, Woodward WA, Middleton LP, Tereffe W, Strom EA, Litton JK, Meric-Bernstam F, Theriault RL, Buchholz TA, Perkins GH (2009) The impact of pregnancy on breast cancer outcomes in women <or = 35 years. Cancer 115:1174–1184
Blakely LJ, Buzdarm AU, Lozada JA, Shullaih SA, Hoy E, Smith TL, Hortobagyi GN (2004) Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence. Cancer 100:465–469
Von Schoultz E, Johansson H, Wilking N, Rutgvist LE (1995) Influence of prior and subsequent pregnancy on breast cancer prognosis. J Clin Oncol 13:430–434
Mueller BA, Simon MS, Deapen D, Kamineni A, Malone KE, Daling JR (2003) Childbearing and survival after breast carcinoma in young women. Cancer 98:1131–1140
Mignot L (1989) Pregnancy after treated cancer of the breast. Results of a case–control. Pathol Biol (Paris) 37:1002
Hemminki K, Försti A, Sundquist J, Ji J (2008) Risk of familial breast cancer is not increased after pregnancy. Breast Cancer Res Treat 108:417–420
Dalberg K, Eriksson J, Holmberg L (2006) Birth outcome in women with previously treated breast cancer—a population-based cohort study from Sweden. PLoS Med 3:e336
Kroman N, Jensen MB, Melbye M, Wohlfahrt J, Mouridsen HT (1997) Should women be advised against pregnancy after breast-cancer treatment? Lancet 350:319–322
Kroman N, Mouridsen HT (2003) Prognostic influence of pregnancy before, around, and after diagnosis of breast cancer. Breast 12:516–521
Velentgas P, Daling JR, Malone KE, Weiss NS, Williams MA, Self SG, Mueller BA (1999) Pregnancy after breast carcinoma: outcomes and influence on mortality. Cancer 85:2424–2432
Ibrahim EM, Ezzat AA, Baloush A, Hussain ZH, Mohammed GH (2000) Pregnancy-associated breast cancer: a case–control study in a young population with a high-fertility rate. Med Oncol 17:293–300
Keleher A, Wendt R III, Delpassand E, Stachowiak AM, Kuerer HM (2004) The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid. Breast J 10:492–495
Murphy CG, Mallam D, Stein S, Patil S, Howard J, Sklarin N, Hudis CA, Gemignani ML, Seidman AD (2012) Current or recent pregnancy is associated with adverse pathologic features but not impaired survival in early breast cancer. Cancer 118:3254–3259
Gelber S, Coates AS, Goldhirsch A, castiglione-Gertsch M, Marini G, Lindtner J, Edelmann DZ, Gudgeon A, Harvey V, Gelber RD, International Breast Cancer Study Group (2001) Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer. J Clin Oncol 19:1671–1675
Cooper DR, Butterfield J (1970) Pregnancy subsequent to mastectomy for cancer of the breast. Ann Surg 171:429–433
Ives A, Saunders C, Bulsara M, Semmens J (2007) Pregnancy after breast cancer: population based study. BMJ 334:194
Largillier R, Savignoni A, Gligorov J, Chollet P, Guilhaume MN, Spielmann M, Luporsi E, Asselain B, coudert B, Namer M, GET(N)A Group (2009) Prognostic role of pregnancy occurring before or after treatment of early breast cancer patients aged <35 years: a GET(N)A working group analysis. Cancer 115:5155–5165
Valachis A, Tsali L, Pesce LL, Polyzos NP, Dimitriadis C, Tsalis K, Mauri D (2010) Safety of pregnancy after primary breast carcinoma in young women: a meta-analysis to overcome bias of healthy mother effect studies. Obstet Gynecol Surv 65:786–793
Azim HA Jr, Santoro L, Russell-Edu W, Pentheroudakis G, Pavlidis N, Peccatori FA (2012) Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies. Cancer Treat Rev 38:834–842
Davies GA, Wolfe LA, Mottola MF, MacKinnon C, Society of Obstetricians and gynecologists of Canada, SOGC Clinical Practice Obstetrics Committee (2003) Joint SOGC/CSEP clinical practice guideline: exercise in pregnancy and the postpartum period. Can J Appl Physiol 28:330–341
Huzarski T, Byrski T, Gronwald J, Gorski B, Domagala P, Cybulski C, Oszurek O, Szwiec M, Gugala K, Stawicka M, Morawiec Z, Mierzwa T, Janiszewska H, Kilar E, Marczyk E, Kozak-Klonowska B, Siolek M, Surdyka D, Wisniowski R, Posmyk M, Sun P, Lubinski J, Narod SA, Polish Breast Cancer Consortium (2013) Ten year survival in BRCA1-negative and BRCA1-positive breast cancer patients. J Clin Oncol 31:3191–3196
Acknowledgments
The authors would like to acknowledge the study coordinators, Roxana Bucur Marcia Llacuachaqui, Alejandra Ragone, Jennifer Ng, Sara Elmi and Linda Steele. Supported by the Canadian Breast Cancer Foundation and the Women’s College Hospital. Also supported by NIH RO1CA74415 (S.L.N.) and P30 CA033752. S.L.N. is the Morris and Horowitz Families Endowed Professor. Recruitment of cases from the City of Hope Clinical Cancer Genetics Community Research Network is supported by Award Number RC4A153828 (PI: J.W.) from the National Cancer Institute and the Office of the Director, National Institutes of Health. The study conducted complies with the current laws of the country in which they were performed.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
The other members of the Hereditary Breast Cancer Clinical Study Group are given in Appendix.
Electronic supplementary material
Below is the link to the electronic supplementary material.
10549_2013_2729_MOESM1_ESM.doc
Fig 4 (supplemental) Breast cancer-specific survival for subjects with and without a pregnancy: from ascertainment (DOC 25 kb)
10549_2013_2729_MOESM2_ESM.doc
Fig 5 (supplemental) Recurrence-free survival in subjects with and without a pregnancy after breast cancer: Follow-up from date of last birth (DOC 25 kb)
Appendix: Other members of the Hereditary Breast Cancer Clinical Study Group
Appendix: Other members of the Hereditary Breast Cancer Clinical Study Group
Jacek Gronwald, Cezary Cybulski, Tomasz Huzarski, Andre Robidoux, Kenneth Offit, Ruth Gershoni-Baruch, Claudine Isaacs, Nadine Tung, Barry Rosen, Rochelle Demsky, Jeanna McCuaig, Andrea Eisen, Louise Bordeleau, Beth Karlan, Judy Garber, Dawna Gilchrist, Charis Eng, Fergus Couch, Gareth Evans, Ava Kwong, Lovise Maehle, Eitan Friedman, Wendy McKinnon, Marie Wood, Mary Daly, Joanne L. Blum, Mark Robson, Albert Chudley, Seema Panchal, Jane McLennan, Barabara Pasini, Gad Rennert, John Lunn, Taya Fallen, Daniel Rayson, Marissa Smith, Ophira Ginsburg, Edmond Lemire, Wendy Meschino, Tuya Pal, Susan Vadaparampil, David Euhus, Josephine Wagner Costalas, Talia Donenberg, Raluca N. Kurz, Susan Friedman (on behalf of FORCE), Kevin Sweet, Carey A. Cullinane, Robert E. Reilly, Joanne Kotsopoulos, Sonia Nanda, Kelly Metcalfe.
Rights and permissions
About this article
Cite this article
Valentini, A., Lubinski, J., Byrski, T. et al. The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation. Breast Cancer Res Treat 142, 177–185 (2013). https://doi.org/10.1007/s10549-013-2729-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-013-2729-1